Internetiühendust pole — kuvatakse lehe salvestatud versioon.

INVENTIVA

FREUR
← Aktsiafiltri Juurde
PA:IVALSE:0RNKUS:IVEVF

INVENTIVA (PA:IVA) — Biotechnology. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 3. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.

Ettevõtte Kohta

Veebileht
inventivapharma.com
Sektor
Healthcare · Biotechnology
Peakontor
Daix, France
Tegevjuht
Andrew Obenshain
Töötajad
87
Ringluses Olevad Aktsiad
236.22 mln
Vabalt Kaubeldavad Aktsiad
165.57 mln
Turukapitalisatsioon
711.02 mln EUR
Siseringi Isikud
12.63%
Institutsionaalsed Investorid
50.05%
Tegevusala (SIC)
Pharmaceutical Preparations
Õiguslik Vorm
K65D
ISIN
FR0013233012
LEI
969500I9Y690B3FZW590
Kirjeldus

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.

reklaam

Börsid ja Tikkerid

BörsTikkerValuutaHindTüüp
PA Euronext ParisIVA põhinoteeringEUR2.77 -2.29%tavalised aktsiad
LSE London Stock Exchange0RNK IOBEUR3.1 +0.00%tavalised aktsiad
US USA StocksIVEVF OTCUSD3.18 -1.24%tavalised aktsiad

Hind 3 Kuu Jooksul

3M1Y3Y5Y
tõususepäev langusepäevViige kursor / puudutage päeva — avamis-, sulgemis-, kõrgeim ja madalaim hind

Suurimad Omanikud

OmanikOsalusAktsiadAruande Kuupäev
Caligan Partners, LP3.91%8.16 mln2026-06-30
Samsara BioCapital, LLC3.02%6.31 mln2026-06-30
Paradigm Biocapital Advi…1.91%4 mln2026-06-30
Andera Partners1.74%3.63 mln2026-06-30
Adar1 Capital Management…1.73%3.61 mln2026-06-30
Millennium Management Ll…1.68%3.51 mln2026-06-30
Nantahala Capital Manage…1.29%2.69 mln2026-06-30
Trails Edge Capital Part…1.27%2.66 mln2026-06-30
Franklin Resources, Inc.1.26%2.64 mln2026-06-30
Squadron Capital Managem…1.17%2.44 mln2026-06-30
abrdn World Healthcare F…0.58%1.21 mln2026-06-30
abrdn Life Sciences Inve…0.52%1.09 mln2026-06-30
Franklin Strategic Serie…0.49%1.01 mln2026-07-31
Fidelity Advisor Series…0.33%685 4002026-07-31
Artisan Partners Funds I…0.27%637 8592026-06-30
Simplify Exchange Traded…0.15%313 4832026-06-30
Fidelity Concord Street…0.07%154 4002026-07-31
Fidelity Concord Street…0.07%136 1612026-07-31
Fidelity Rutland Square…0.03%63 6782026-07-31
Blackstone Alternative I…0.02%42 7522026-06-30
Fidelity Concord Street…0.01%29 3002026-07-31
-SSgA SPDR ETFS Europe I…0.01%16 4092026-07-31
-SSgA SPDR ETFS Europe I…0%9 8432026-07-31
-SSgA SPDR ETFS Europe I…0%3 7042026-07-31
DBX ETF Trust-Xtrackers…0%1 3272026-05-31
-Goldman Sachs MSCI Worl…0%3012026-08-31